{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreignfoxlv54rotfxxsu4wds3krzt3p2jgqwk3wwld7pmqka7ugnimm",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mnrwgnytpzm2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreibecu6zn7swbobck4z5sj3a67tcundbvwvi5um2he5pmkhc4idarm"
    },
    "mimeType": "image/jpeg",
    "size": 570949
  },
  "path": "/news/2026-06-ozempic-gpl-1s-curb-substance.html",
  "publishedAt": "2026-06-08T10:40:13.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "A new study led by researchers at the University of Texas at El Paso found that use of weight-loss drugs like Ozempic and other GLP-1s is associated with a lower risk of developing alcohol, opioid, nicotine and cocaine use disorders.",
  "title": "Ozempic, GPL-1s may help curb substance use disorders, study finds"
}